RETARDEMENT DE LA PROGRESSION DE LA MALADIE OU SURVIE DES PATIENTS ATTEINTS DU CANCER

• 收藏
• 分享

专利权人:

INC.;GENENTECH

发明人:

DERYNCK, MIKA K.,KELSEY, STEPHEN M.

申请号：

CA2596133

公开号：

CA2596133C

申请日:

2006.02.21

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

The present application describes extending time to disease progression orsurvival in a cancerpatient, where the patient's cancer displays HER activation, by treating thepatient with a HERdimerization inhibitor, such as pertuzumab, including the use of a 420 mgfixed dosage form soas to extend measured time to disease progression or survival in breast cancerpatients.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/